News of the WeekGene Therapy

β-Thalassemia Treatment Succeeds, With a Caveat

+ See all authors and affiliations

Science  11 Dec 2009:
Vol. 326, Issue 5959, pp. 1468-1469
DOI: 10.1126/science.326.5959.1468-b

You are currently viewing the summary.

View Full Text

Summary

Gene therapy researchers are approaching a key milestone: They appear to have controlled an inherited blood disorder called β-thalassemia that's more common than any disease treated so far with gene therapy. A young man who received new genes to repair blood cells no longer needs regular transfusions and, 2 years later, seems healthy. Describing this success last week to a U.S. review panel in Bethesda, Maryland, a researcher added a caveat: The inserted gene may have turned on growth signals, raising the potential for cancer.